Business Context and Reporting Period
This Form 8-K filing by MediciNova, Inc. (Delaware) reports a corporate governance event dated June 1, 2018. The company is headquartered in La Jolla, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure: Ryan Selhorn resigned as Chief Financial Officer (CFO) effective June 1, 2018. Mr. Selhorn had served in this role through a services agreement with Signature Analytics San Diego LLC.
- Appointment: Carla Reyes was appointed as the new Chief Financial Officer and principal financial officer effective June 1, 2018.
- Compensation Structure: Ms. Reyes's services are provided under an amended Services Agreement with Signature Analytics. The company will pay pre-approved hourly rates. The agreement term expires on March 31, 2019, subject to earlier termination.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, risk factors, or management commentary regarding the company's business outlook. It notes that Ms. Reyes has no family relationships with other directors or officers and holds no material interests in transactions requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the transition timeline for financial reporting responsibilities between the outgoing and incoming CFO.
- Confirm the specific hourly rates and total estimated cost under the amended Services Agreement with Signature Analytics.
- Review Ms. Reyes's prior experience at Rady Children's Hospital and other firms to assess fit for a biopharmaceutical CFO role.
- Check for any subsequent filings regarding the appointment of a permanent internal CFO versus continued reliance on a third-party services firm.